BUZZ-U.S. Stocks on the Move-Salix, Abbvie, Shire, Astrazeneca, Tekmira, CF
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index e-mini futures were lower on Tuesday: Dow Jones industrial average futures were down 0.26 percent at 17,054, S&P 500 futures were down 0.33 percent at 1,979.75 and Nasdaq 100 futures were down 0.36 percent at 4,038.25.
** SALIX PHARMACEUTICALS LTD Monday close $159.83, +8.87 pct premarket
** ALLERGAN INC, Monday close $166.12
** VALEANT PHARMACEUTICALS INC, Monday close $116.28
Allergan has revived discussions to buy Salix, but the exact status of the discussions between the two drugmakers could not be immediately established.
The botox maker is trying to seal a deal with Salix in order to fend off a $53 billion hostile offer from Valeant. Salix said in July it would merge with an Irish subsidiary of Cosmo Pharmaceuticals SpA in a so-called tax inversion.
** ASTRAZENECA PLC, Monday close $74.67, -4.58 pct premarket
** SHIRE PLC, Monday close $256.3, -5.70 pct premarket Continued...